{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:54:44Z","timestamp":1788069284190,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00208004"],"award-info":[{"award-number":["RS-2023-00208004"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science & ICT","award":["NRF-2021M3A9I4026318"],"award-info":[{"award-number":["NRF-2021M3A9I4026318"]}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"crossref","award":["No. 800-20220113"],"award-info":[{"award-number":["No. 800-20220113"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AI-Bio Research Grant through Seoul National University, the NAVER Corporation","award":["No. 3720230110"],"award-info":[{"award-number":["No. 3720230110"]}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"crossref","award":["No. 0320233070"],"award-info":[{"award-number":["No. 0320233070"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04191-9","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:55:28Z","timestamp":1770641728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Controlled-release nanoparticle of toll-like receptors-7\/8 agonist enhances immune activation and inhibits gastric cancer in a preclinical mouse model"],"prefix":"10.1186","volume":"26","author":[{"given":"Hyun Myong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Mo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yie-Ri","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yeon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Joong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk-Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Kwang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Youn","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Taik","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keehoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Ho","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"4191_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092639","author":"WS Shin","year":"2023","unstructured":"Shin WS, Xie F, Chen B, Yu P, Yu J, To KF, et al. Updated epidemiology of gastric cancer in Asia: decreased incidence but still a big challenge. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15092639.","journal-title":"Cancers (Basel)"},{"key":"4191_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072636","author":"Y Narita","year":"2023","unstructured":"Narita Y, Muro K. Updated immunotherapy for gastric cancer. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12072636.","journal-title":"J Clin Med"},{"key":"4191_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1285343","volume":"14","author":"K Liu","year":"2023","unstructured":"Liu K, Yuan S, Wang C, Zhu H. Resistance to immune checkpoint inhibitors in gastric cancer. Front Pharmacol. 2023;14:1285343.","journal-title":"Front Pharmacol"},{"issue":"4","key":"4191_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/CJI.0b013e3182518e83","volume":"35","author":"Y Liu","year":"2012","unstructured":"Liu Y, Zeng G. Cancer and innate immune system interactions: translational potentials for cancer immunotherapy. J Immunother. 2012;35(4):299\u2013308.","journal-title":"J Immunother"},{"key":"4191_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","volume":"13","author":"T Duan","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774.","journal-title":"Front Immunol"},{"issue":"5","key":"4191_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. 2011;34(5):637\u201350.","journal-title":"Immunity"},{"key":"4191_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.611444","volume":"8","author":"L Cui","year":"2020","unstructured":"Cui L, Wang X, Zhang D. TLRs as a promise target along with immune checkpoint against gastric cancer. Front Cell Dev Biol. 2020;8:611444.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4191_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2217\/imt-2021-0103","volume":"14","author":"C Kole","year":"2022","unstructured":"Kole C, Charalampakis N, Tsakatikas S, Kouris NI, Papaxoinis G, Karamouzis MV, et al. Immunotherapy for gastric cancer: a 2021 update. Immunotherapy. 2022;14(1):41\u201364.","journal-title":"Immunotherapy"},{"key":"4191_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.123032","volume":"316","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li Y, Xu Z, Xu L, Wang Y, Li N, et al. PPS-TLR7\/8 agonist nanoparticles equip robust anticancer immunity by selectively prolonged activation of dendritic cells. Biomaterials. 2025;316:123032.","journal-title":"Biomaterials"},{"issue":"13","key":"4191_CR10","doi-asserted-by":"publisher","first-page":"e2307694","DOI":"10.1002\/smll.202307694","volume":"20","author":"YJ Yoo","year":"2024","unstructured":"Yoo YJ, Eun R, Park HM, Kim S, Park SH, Heo J, et al. Nanoengineered macrophages armed with TLR7\/8 agonist enhance remodeling of immunosuppressive tumor microenvironment. Small. 2024;20(13):e2307694.","journal-title":"Small"},{"key":"4191_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11091503","author":"S Kim","year":"2023","unstructured":"Kim S, Park Y, Kim J, Kim S, Choi K, Kang T, et al. Prolonged liposomal delivery of TLR7\/8 agonist for enhanced cancer vaccine. Vaccines (Basel). 2023. https:\/\/doi.org\/10.3390\/vaccines11091503.","journal-title":"Vaccines (Basel)"},{"issue":"27","key":"4191_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202401270","volume":"13","author":"S Park","year":"2024","unstructured":"Park S, Jin SM, Kim S, Cho JH, Hong J, Bae YS, et al. Bioconjugated antibody-trojan immune converter enhance cancer immunotherapy with minimized toxicity by programmed two-step immunomodulation of myeloid cells. Adv Healthc Mater. 2024;13(27):e2401270.","journal-title":"Adv Healthc Mater"},{"key":"4191_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202411747","author":"SN Lee","year":"2024","unstructured":"Lee SN, Park SH, Choi J-H, Heo J, Lee M-H, Oh S-S, et al. Virulence-free reconstituted synthetic nanopathogen empowered by timely\u2010activating TLR agonist promotes heterologous cancer immunotherapy with depletion of tumor\u2010specific Treg cells. Adv Funct Mater. 2024. https:\/\/doi.org\/10.1002\/adfm.202411747.","journal-title":"Adv Funct Mater"},{"issue":"9","key":"4191_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41423-025-01306-6","volume":"22","author":"YJ Yoo","year":"2025","unstructured":"Yoo YJ, Kim S, Wickramasinghe A, Kim J, Song J, Kim YI, et al. Multiscale dynamic immunomodulation by a nanoemulsified trojan-TLR7\/8 adjuvant for robust protection against heterologous pandemic and endemic viruses. Cell Mol Immunol. 2025;22(9):1045\u201360.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"4191_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2174\/0118744710258313231105072931","volume":"17","author":"L Corrie","year":"2024","unstructured":"Corrie L, Kommineni N, Kaur J, Awasthi A, Gundaram R, Kukati L. In situ photo responsive biodegradable nanoparticle forming intrauterine implant for drug delivery to treat ovarian diseases: a rationale-based review. Curr Radiopharm. 2024;17(4):313\u20139.","journal-title":"Curr Radiopharm"},{"issue":"9","key":"4191_CR16","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.tibtech.2023.03.008","volume":"41","author":"BA Jackson Hoffman","year":"2023","unstructured":"Jackson Hoffman BA, Pumford EA, Enueme AI, Fetah KL, Friedl OM, Kasko AM. Engineered macromolecular toll-like receptor agents and assemblies. Trends Biotechnol. 2023;41(9):1139\u201354.","journal-title":"Trends Biotechnol"},{"issue":"4","key":"4191_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/imm.12622","volume":"148","author":"TY Wu","year":"2016","unstructured":"Wu TY. Strategies for designing synthetic immune agonists. Immunology. 2016;148(4):315\u201325.","journal-title":"Immunology"},{"issue":"42","key":"4191_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201903242","volume":"31","author":"H Phuengkham","year":"2019","unstructured":"Phuengkham H, Song C, Lim YT. A designer scaffold with immune nanoconverters for reverting immunosuppression and enhancing immune checkpoint blockade therapy. Adv Mater. 2019;31(42):e1903242.","journal-title":"Adv Mater"},{"issue":"1","key":"4191_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11730-8","volume":"10","author":"C Song","year":"2019","unstructured":"Song C, Phuengkham H, Kim YS, Dinh VV, Lee I, Shin IW, et al. Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence. Nat Commun. 2019;10(1):3745.","journal-title":"Nat Commun"},{"issue":"11","key":"4191_CR20","doi-asserted-by":"publisher","first-page":"12671","DOI":"10.1021\/acsnano.9b04207","volume":"13","author":"SY Kim","year":"2019","unstructured":"Kim SY, Kim S, Kim JE, Lee SN, Shin IW, Shin HS, et al. Lyophilizable and multifaceted toll-like receptor 7\/8 agonist-loaded nanoemulsion for the reprogramming of tumor microenvironments and enhanced cancer immunotherapy. ACS Nano. 2019;13(11):12671\u201386.","journal-title":"ACS Nano"},{"issue":"1","key":"4191_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.coi.2012.11.006","volume":"25","author":"LC West","year":"2013","unstructured":"West LC, Cresswell P. Expanding roles for GILT in immunity. Curr Opin Immunol. 2013;25(1):103\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"4191_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/CMR.0000000000000230","volume":"26","author":"J Nguyen","year":"2016","unstructured":"Nguyen J, Bernert R, In K, Kang P, Sebastiao N, Hu C, et al. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma. Melanoma Res. 2016;26(2):125\u201337.","journal-title":"Melanoma Res"},{"issue":"4","key":"4191_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41565-022-01296-w","volume":"18","author":"SM Jin","year":"2023","unstructured":"Jin SM, Yoo YJ, Shin HS, Kim S, Lee SN, Lee CH, et al. A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion. Nat Nanotechnol. 2023;18(4):390\u2013402.","journal-title":"Nat Nanotechnol"},{"issue":"7","key":"4191_CR24","first-page":"553","volume":"21","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang S, Zhang H, Meng Y, Jiao S, An L, et al. Modeling human gastric cancers in immunocompetent mice. Cancer Biol Med. 2024;21(7):553\u201370.","journal-title":"Cancer Biol Med"},{"issue":"7","key":"4191_CR25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/jgh.13297","volume":"31","author":"AR Poh","year":"2016","unstructured":"Poh AR, O\u2019Donoghue RJ, Ernst M, Putoczki TL. Mouse models for gastric cancer: matching models to biological questions. J Gastroenterol Hepatol. 2016;31(7):1257\u201372.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7517","key":"4191_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive molecular characterization of gastric adenocarcinoma","year":"2014","unstructured":"Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"19","key":"4191_CR27","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1158\/0008-5472.CAN-17-0061","volume":"77","author":"JE Till","year":"2017","unstructured":"Till JE, Yoon C, Kim BJ, Roby K, Addai P, Jonokuchi E, et al. Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-Cadherin expression. Cancer Res. 2017;77(19):5349\u201359.","journal-title":"Cancer Res"},{"key":"4191_CR28","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429318398240918063450","volume":"17","author":"X Zhang","year":"2024","unstructured":"Zhang X, Jin M, Yao X, Liu J, Yang Y, Huang J, et al. Upregulation of LncRNA WT1-AS inhibits tumor growth and promotes autophagy in gastric cancer via suppression of PI3K\/Akt\/mTOR pathway. Curr Mol Pharmacol. 2024;17:e18761429318398.","journal-title":"Curr Mol Pharmacol"},{"key":"4191_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409914","author":"SM Jin","year":"2024","unstructured":"Jin SM, Cho JH, Gwak Y, Park SH, Choi K, Choi JH, et al. Transformable gel-to-nanovaccine enhances cancer immunotherapy via metronomic-like immunomodulation and collagen-mediated paracortex delivery. Adv Mater. 2024. https:\/\/doi.org\/10.1002\/adma.202409914.","journal-title":"Adv Mater"},{"issue":"10","key":"4191_CR30","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1021\/acs.accounts.0c00337","volume":"53","author":"SN Lee","year":"2020","unstructured":"Lee SN, Jin SM, Shin HS, Lim YT. Chemical strategies to enhance the therapeutic efficacy of Toll-like receptor agonist based cancer immunotherapy. Acc Chem Res. 2020;53(10):2081\u201393.","journal-title":"Acc Chem Res"},{"key":"4191_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193410","volume":"16","author":"A Ghebremedhin","year":"2024","unstructured":"Ghebremedhin A, Athavale D, Zhang Y, Yao X, Balch C, Song S. Tumor-associated macrophages as major immunosuppressive cells in the tumor microenvironment. Cancers (Basel). 2024;16:19.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4191_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","volume":"21","author":"J Liu","year":"2021","unstructured":"Liu J, Geng X, Hou J, Wu G. New insights into M1\/M2 macrophages: key modulators in cancer progression. Cancer Cell Int. 2021;21(1):389.","journal-title":"Cancer Cell Int"},{"key":"4191_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1199173","volume":"14","author":"YL Yang","year":"2023","unstructured":"Yang YL, Yang F, Huang ZQ, Li YY, Shi HY, Sun Q, et al. T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems. Front Immunol. 2023;14:1199173.","journal-title":"Front Immunol"},{"key":"4191_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1282176","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Hu C, Zhang R, Xu J, Zhang Y, Yuan L, et al. The role of macrophages in gastric cancer. Front Immunol. 2023;14:1282176.","journal-title":"Front Immunol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04191-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04191-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04191-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:55:22Z","timestamp":1773831322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04191-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4191"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04191-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed. Animal care and handling procedures were performed in accordance with the Seoul National University Hospital Biomedical Research Institute guidelines (No. 23-0052-S1A0).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}